Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Proprietary compound preparation BNF 1203050
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Biotene dry mouth antibacterial toothpaste original
120305000BBAEA0
|
Proprietary compound preparation BNF 1203050 | Other treatment of dry mouth preparations | Ear, Nose and Oropharynx | 2,520 |
|
Xerostom dry mouth spray
120305000BBAWA0
|
Proprietary compound preparation BNF 1203050 | Other treatment of dry mouth preparations | Ear, Nose and Oropharynx | 93 |
|
Biotene dry mouth gum
120305000BBAHA0
|
Proprietary compound preparation BNF 1203050 | Other treatment of dry mouth preparations | Ear, Nose and Oropharynx | No data available |
|
Biotene Oralbalance dry mouth moisturising liquid
120305000BBATA0
|
Proprietary compound preparation BNF 1203050 | Other treatment of dry mouth preparations | Ear, Nose and Oropharynx | No data available |
|
Biotene Oralbalance dry mouth system
120305000BBAFA0
|
Proprietary compound preparation BNF 1203050 | Other treatment of dry mouth preparations | Ear, Nose and Oropharynx | No data available |
|
BioXtra 50unit medicated chewing gum
120305000BBAKA0
|
Proprietary compound preparation BNF 1203050 | Other treatment of dry mouth preparations | Ear, Nose and Oropharynx | No data available |
|
BioXtra 50unit sucking tablets
120305000BBAUA0
|
Proprietary compound preparation BNF 1203050 | Other treatment of dry mouth preparations | Ear, Nose and Oropharynx | No data available |
|
Xerostom Mucosa gel
120305000BBAZA0
|
Proprietary compound preparation BNF 1203050 | Other treatment of dry mouth preparations | Ear, Nose and Oropharynx | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.